The global rheumatoid arthritis drugs market size is expected to Reach US$ 26.758 bn by 2026. It is anticipated to expand at a stable CAGR of more than 2.7% between 2019 and 2026. Expansion of the global rheumatoid arthritis drugs market is due to strong research & development and increasing awareness regarding usage of biologic drugs for rheumatoid arthritis treatment during the forecast period. The rheumatoid arthritis drugs market in Asia Pacific is expanding with a high potential to grow, registering a CAGR of more than 3.0% due to the high prevalence of diseases, development in health care sector, and increased focus on research and developmental activities in the region.
The report analyzes and forecasts the rheumatoid arthritis drugs market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of rheumatoid arthritis drugs, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major rheumatoid arthritis drugs companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of rheumatoid arthritis drugs upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of rheumatoid arthritis drugs and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global rheumatoid arthritis drugs market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the rheumatoid arthritis drugs market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of rheumatoid arthritis drugs market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Companies Mentioned in Report
The report also profiles major players in the global rheumatoid arthritis drugs market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players operating in the global rheumatoid arthritis drugs market include Pfizer, Inc., Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Bristol-Myers Squibb Company, and Eli Lilly and Company.
Report Segmentation:
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
3.1. Global Rheumatoid Arthritis Drugs Market: Market Snapshot
4. Market Overview
4.1. Global Rheumatoid Arthritis Drugs Market: Product Overview
4.2. Global Rheumatoid Arthritis Drugs Market: Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Rheumatoid Arthritis Drugs Market Revenue Projections, 2019–2026
4.5. Porter’s Five Forces Analysis
5. Market Outlook
5.1. Pipeline analysis
5.2. Brand Analysis
5.3. Key Mergers and Acquisitions
6. Global Rheumatoid Arthritis Drugs Market Analysis, by Drug Type
6.1. Key Findings
6.2. Introduction
6.3. Global Rheumatoid Arthritis Drugs Market Value Share Analysis, by Drug Type
6.4. Global Rheumatoid Arthritis Drugs Market Value Forecast, by Drug Type
6.4.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS)
6.4.2. Corticosteroids
6.4.3. Disease Modifying Anti-rheumatic Drugs (DMARDs)
6.4.4. Biologic Response Modifiers (Biologics)
6.5. Global Rheumatoid Arthritis Drugs Market Attractiveness Analysis, by Drug Type
7. Global Rheumatoid Arthritis Drugs Market Analysis, by Distribution Channel
7.1. Key Findings
7.2. Introduction
7.3. Global Rheumatoid Arthritis Drugs Market Value Share Analysis, by Distribution Channels
7.4. Global Rheumatoid Arthritis Drugs Market Value Forecast, by Distribution Channel
7.4.1. Hospital Pharmacy
7.4.2. Retail Pharmacy
7.4.3. Online Pharmacy
7.5. Global Rheumatoid Arthritis Drugs Market Attractiveness Analysis, by Distribution Channels
8. Global Rheumatoid Arthritis Drugs Market Analysis, by Region
8.1. Key Findings
8.2. Global Rheumatoid Arthritis Drugs Market Scenario, by Country
8.3. Global Rheumatoid Arthritis Drugs Market Value Share Analysis, by Region
8.4. Global Rheumatoid Arthritis Drugs Market Value Forecast, by Region
8.4.1. North America
8.4.2. Europe
8.4.3. Asia Pacific
8.4.4. Latin America
8.4.5. Middle East & Africa
8.5. Global Rheumatoid Arthritis Drugs Market Attractiveness Analysis, by Region
9. North America Rheumatoid Arthritis Drugs Market Analysis
9.1. Key Findings
9.2. North America Rheumatoid Arthritis Drugs Market Overview
9.3. North America Rheumatoid Arthritis Drugs Market Value Share Analysis, by Country
9.4. North America Rheumatoid Arthritis Drugs Market Forecast, by Country
9.4.1. U.S.
9.4.2. Canada
9.5. North America Rheumatoid Arthritis Drugs Market Value Share Analysis, by Drug Type
9.6. North America Rheumatoid Arthritis Drugs Market Forecast, by Drug Type
9.6.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS)
9.6.2. Corticosteroids
9.6.3. Disease Modifying Anti-rheumatic Drugs (DMARDs)
9.6.4. Biologic Response Modifiers (Biologics)
9.7. North America Rheumatoid Arthritis Drugs Market Value Share Analysis, by Distribution Channel
9.8. North America Rheumatoid Arthritis Drugs Market Forecast, by Distribution Channel
9.8.1. Hospital Pharmacy
9.8.2. Retail Pharmacy
9.8.3. Online Pharmacy
9.9. North America Rheumatoid Arthritis Drugs Market Attractiveness Analysis
10. Europe Rheumatoid Arthritis Drugs Market Analysis
10.1. Key Findings
10.2. Europe Rheumatoid Arthritis Drugs Market Overview
10.3. Europe Rheumatoid Arthritis Drugs Market Value Share Analysis, by Country
10.4. Europe Rheumatoid Arthritis Drugs Market Forecast, by Country
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Europe Rheumatoid Arthritis Drugs Market Value Share Analysis, by Drug Type
10.6. Europe Rheumatoid Arthritis Drugs Market Forecast, by Drug Type
10.6.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS)
10.6.2. Corticosteroids
10.6.3. Disease Modifying Anti-rheumatic Drugs (DMARDs)
10.6.4. Biologic Response Modifiers (Biologics)
10.7. Europe Rheumatoid Arthritis Drugs Market Value Share Analysis, by Distribution Channel
10.8. Europe Rheumatoid Arthritis Drugs Market Forecast, by Distribution Channel
10.8.1. Hospital Pharmacy
10.8.2. Retail Pharmacy
10.8.3. Online Pharmacy
10.9. Europe Rheumatoid Arthritis Drugs Market Attractiveness Analysis
11. Asia Pacific Rheumatoid Arthritis Drugs Market Analysis
11.1. Key Findings
11.2. Asia Pacific Rheumatoid Arthritis Drugs Market Overview
11.3. Asia Pacific Rheumatoid Arthritis Drugs Market Value Share Analysis, by Country
11.4. Asia Pacific Rheumatoid Arthritis Drugs Market Forecast, by Country
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Rheumatoid Arthritis Drugs Market Value Share Analysis, by Drug Type
11.6. Asia Pacific Rheumatoid Arthritis Drugs Market Forecast, by Drug Type
11.6.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS)
11.6.2. Corticosteroids
11.6.3. Disease Modifying Anti-rheumatic Drugs (DMARDs)
11.6.4. Biologic Response Modifiers (Biologics)
11.7. Asia Pacific Rheumatoid Arthritis Drugs Market Value Share Analysis, by Distribution Channel
11.8. Asia Pacific Rheumatoid Arthritis Drugs Market Forecast, by Distribution Channel
11.8.1. Hospital Pharmacy
11.8.2. Retail Pharmacy
11.8.3. Online Pharmacy
11.9. Asia Pacific Rheumatoid Arthritis Drugs Market Attractiveness Analysis
12. Latin America Rheumatoid Arthritis Drugs Market Analysis
12.1. Key Findings
12.2. Latin America Rheumatoid Arthritis Drugs Market Overview
12.3. Latin America Rheumatoid Arthritis Drugs Market Value Share Analysis, by Country
12.4. Latin America Rheumatoid Arthritis Drugs Market Forecast, by Country
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Rheumatoid Arthritis Drugs Market Value Share Analysis, by Drug Type
12.6. Latin America Rheumatoid Arthritis Drugs Market Forecast, by Drug Type
12.6.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS)
12.6.2. Corticosteroids
12.6.3. Disease Modifying Anti-rheumatic Drugs (DMARDs)
12.6.4. Biologic Response Modifiers (Biologics)
12.6.5. Enteral needles
12.7. Latin America Rheumatoid Arthritis Drugs Market Value Share Analysis, by Distribution Channel
12.7.1. Hospital Pharmacy
12.7.2. Retail Pharmacy
12.7.3. Online Pharmacy
12.8. Latin America Rheumatoid Arthritis Drugs Market Forecast, by Distribution Channel
12.9. Latin America Rheumatoid Arthritis Drugs Market Attractiveness Analysis
13. Middle East & Africa Rheumatoid Arthritis Drugs Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Rheumatoid Arthritis Drugs Market Overview
13.3. Middle East & Africa Rheumatoid Arthritis Drugs Market Value Share Analysis, by Country
13.4. Middle East & Africa Rheumatoid Arthritis Drugs Market Forecast, by Country
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East and Africa
13.5. Middle East & Africa Rheumatoid Arthritis Drugs Market Value Share Analysis, by Drug Type
13.6. Middle East & Africa Rheumatoid Arthritis Drugs Market Forecast, by Drug Type
13.6.1. Nonsteroidal Anti-inflammatory Drugs (NSAIDS)
13.6.2. Corticosteroids
13.6.3. Disease Modifying Anti-rheumatic Drugs (DMARDs)
13.6.4. Biologic Response Modifiers (Biologics)
13.7. Middle East & Africa Rheumatoid Arthritis Drugs Market Value Share Analysis, by Distribution Channel
13.8. Middle East & Africa Rheumatoid Arthritis Drugs Market Forecast, by Distribution Channel
13.8.1. Hospital Pharmacy
13.8.2. Retail Pharmacy
13.8.3. Online Pharmacy
13.9. Middle East & Africa Rheumatoid Arthritis Drugs Market Attractiveness Analysis
14. Competitive Landscape
14.1. Company Profiles
14.1.1. AbbVie, Inc.
14.1.1.1. Company Details
14.1.1.2. Business Overview
14.1.1.3. Financial Overview
14.1.1.4. Strategic Overview
14.1.1.5. SWOT Analysis
14.1.2. Janssen Biotech, Inc.
14.1.2.1. Company Details
14.1.2.2. Business Overview
14.1.2.3. Financial Overview
14.1.2.4. Strategic Overview
14.1.2.5. SWOT Analysis
14.1.3. Amgen, Inc.
14.1.3.1. Company Details
14.1.3.2. Business Overview
14.1.3.3. Financial Overview
14.1.3.4. Strategic Overview
14.1.3.5. SWOT Analysis
14.1.4. Pfizer, Inc.
14.1.4.1. Company Details
14.1.4.2. Business Overview
14.1.4.3. Financial Overview
14.1.4.4. Strategic Overview
14.1.4.5. SWOT Analysis
14.1.5. Novartis AG
14.1.5.1. Company Details
14.1.5.2. Business Overview
14.1.5.3. Financial Overview
14.1.5.4. Strategic Overview
14.1.5.5. SWOT Analysis
14.1.6. Sanofi S.A.
14.1.6.1. Company Details
14.1.6.2. Business Overview
14.1.6.3. Financial Overview
14.1.6.4. Strategic Overview
14.1.6.5. SWOT Analysis
14.1.7. F. Hoffmann-La Roche Ltd.
14.1.7.1. Company Details
14.1.7.2. Business Overview
14.1.7.3. Financial Overview
14.1.7.4. Strategic Overview
14.1.7.5. SWOT Analysis
14.1.8. Merck & Co.
14.1.8.1. Company Details
14.1.8.2. Business Overview
14.1.8.3. Financial Overview
14.1.8.4. Strategic Overview
14.1.8.5. SWOT Analysis
14.1.9. Bristol-Myers Squibb Company
14.1.9.1. Company Details
14.1.9.2. Business Overview
14.1.9.3. Financial Overview
14.1.9.4. Strategic Overview
14.1.9.5. SWOT Analysis
14.1.10. Eli Lilly and Company
14.1.10.1. Company Details
14.1.10.2. Business Overview
14.1.10.3. Financial Overview
14.1.10.4. Strategic Overview
14.1.10.5. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers